Fig 1.
Patient flowchart reporting numbers of individuals at each stage of study.
Legend: DM: diabetes mellitus; HIV: human immunodeficiency virus; US: peripheral nerve ultrasonography; MDT: multi-drug therapy.
Table 1.
Clinical data for the patients included in the study.
Table 2.
CSA results before and after treatment in PB and MB patients.
Table 3.
CSA results before and after treatment in patients without and with reactions.
Table 4.
Asymmetry measurements (ΔCSA and ΔUtpt) before and after treatment in patients without and with reactions.
Table 5.
Frequency of poor CSA outcomes after treatment in patients without and with reactions.